Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.19B | 2.18B | 2.24B | 2.58B | 1.62B | 976.59M |
Gross Profit | 472.81M | 474.06M | 466.10M | 556.75M | 372.91M | 187.81M |
EBITDA | 165.08M | 169.82M | 161.86M | 343.35M | 184.79M | 90.02M |
Net Income | 39.93M | 46.48M | 36.05M | 128.67M | 103.14M | 28.03M |
Balance Sheet | ||||||
Total Assets | 1.47B | 1.40B | 1.23B | 1.43B | 1.11B | 459.52M |
Cash, Cash Equivalents and Short-Term Investments | 24.43M | 33.74M | 13.00M | 65.07M | 7.76M | 457.98K |
Total Debt | 673.53M | 623.07M | 564.03M | 789.86M | 570.59M | 166.61M |
Total Liabilities | 839.89M | 763.08M | 705.25M | 922.00M | 700.89M | 220.06M |
Stockholders Equity | 633.78M | 634.57M | 526.87M | 506.97M | 414.03M | 239.46M |
Cash Flow | ||||||
Free Cash Flow | 93.13M | 133.54M | 226.30M | 199.88M | -72.88M | 61.75M |
Operating Cash Flow | 103.28M | 142.75M | 238.08M | 210.69M | -65.42M | 64.19M |
Investing Cash Flow | -159.07M | -147.46M | -13.48M | -279.47M | -306.63M | ― |
Financing Cash Flow | 59.80M | 30.00M | -285.99M | 128.61M | 378.85M | ― |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | C$769.05M | 12.11 | 10.01% | 6.37% | 14.87% | -16.06% | |
75 Outperform | C$660.04M | 7.68 | 10.37% | 4.79% | -2.42% | -4.60% | |
73 Outperform | C$505.43M | 12.33 | 8.09% | 5.99% | -2.65% | -47.65% | |
68 Neutral | C$744.55M | 13.28 | 6.81% | 0.06% | 3.01% | 2.15% | |
63 Neutral | kr60.99B | 12.81 | 1.88% | 2.31% | 0.19% | -4.61% | |
50 Neutral | C$1.23B | ― | -9.26% | 4.00% | 1.70% | -154.73% | |
― | $1.88B | 17.54 | 9.30% | 0.12% | ― | ― |
ADENTRA Inc. has announced it will release its second quarter 2025 financial results on August 6, 2025, after market close. The following day, a conference call will be held by CEO Rob Brown and CFO Faiz Karmally to discuss the company’s financial performance, providing stakeholders with insights into ADENTRA’s operational and market positioning.
The most recent analyst rating on (TSE:ADEN) stock is a Buy with a C$51.00 price target. To see the full list of analyst forecasts on ADENTRA stock, see the TSE:ADEN Stock Forecast page.
ADENTRA Inc. reported first quarter 2025 sales of $542.5 million, marking a 1.4% increase from the previous year, despite challenges such as adverse weather and a softer residential construction market. The company maintained a stable gross margin of 21.6% and managed to offset a decline in organic sales with acquisition-based growth. ADENTRA is preparing for ongoing trade uncertainties by taking precautionary inventory measures and remains focused on maintaining its financial stability and shareholder returns.